1H NMR and hyperpolarized 13C NMR assays of pyruvate-lactate: A comparative study

NMR in Biomedicine

Volumn 26, Issue 10, 2013, Pages 1321-1325

  Hill, Deborah K ^a   Jamin, Yann ^a   Orton, Matthew R ^a   Tardif, Nicolas ^a   Parkes, Harold G ^a   Robinson, Simon P ^a   Leach, Martin O ^a   Chung, Yuen Li ^a   Eykyn, Thomas R ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

13C NMR; 1H NMR; Cancer; Hyperpolarized pyruvate; Lactate; Lactate dehydrogenase activity

Indexed keywords

BACKWARD REACTIONS; CANCER; COLORECTAL CARCINOMA; COMPARATIVE STUDIES; LACTATE; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE ACTIVITIES; PYRUVATES;

KINETICS; LAKES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RATE CONSTANTS; STATISTICS;

ASSAYS;

CARBON; CARBON 13; LACTATE DEHYDROGENASE; LACTIC ACID; PYRUVIC ACID;

ARTICLE; CANCER CELL; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL ANALYSIS; COMPARATIVE STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYPERPOLARIZATION; ISOTOPE LABELING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REPRODUCIBILITY; SPECTROMETER;

13C NMR; 1H NMR; CANCER; HYPERPOLARIZED PYRUVATE; LACTATE; LACTATE DEHYDROGENASE ACTIVITY;

CARBON ISOTOPES; CELL LINE, TUMOR; HUMANS; L-LACTATE DEHYDROGENASE; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; PROTONS; PYRUVIC ACID;

EID: 84883749509     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2957     Document Type: Article

References (22)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144(5): 646-674.
2. Heiden MGV, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324(5930): 1029-1033.
3. Schwartz MK. Enzymes as prognostic markers and therapeutic indicators in patients with cancer. Clin. Chim. Acta 1992; 206(1-2): 77-82.
4. Shim H, Dolde C, Lewis BC, Wu CS, Dang G, Jungmann RA, Dalla-Favera R, Dang CV. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. USA 1997; 94(13): 6658-6663.
5. Bouafia F, Drai J, Bienvenu J, Thieblemont C, Espinouse D, Salles G, Coiffier B. Profiles and prognostic values of serum LDH isoenzymes in patients with haematopoietic malignancies. Bull. Cancer 2004; 91(7-8): E229-E240.
6. Williamson DH, Lund P, Krebs HA. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem. J. 1967; 103(2): 514-527.
7. Jamin Y, Smyth L, Robinson SP, Poon ES, Eykyn TR, Springer CJ, Leach MO, Payne GS. Noninvasive detection of carboxypeptidase G2 activity in vivo. NMR Biomed. 2010; 24(4): 343-350.
8. Beloueche-Babari M, Workman P, Leach MO. Exploiting tumor metabolism for non-invasive imaging of the therapeutic activity of molecularly targeted anticancer agents. Cell Cycle 2011; 10(17): 2883-2893.
9. Tennant DA, Duran RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nat. Rev. Cancer 2010; 10(4): 267-277.
10. Garber K. Oncology's energetic pipeline. Nat. Biotechnol. 2010; 28(9): 888-891.
11. Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin. Cancer Res. 2009; 15(21): 6479-6483.
12. Feron O. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother. Oncol. 2009; 92(3): 329-333.
13. 13C magnetic resonance imaging and spectroscopy. Nat. Med. 2007; 13(11): 1382-1387.
14. Bain AD. Chemical exchange in NMR. Prog. Nucl. Magn. Reson. Spectrosc. 2003; 43(3-4): 63-103.
15. 13C]lactate in a murine lymphoma. Magn. Reson. Med. 2010; 63(4): 872-880.
16. Ward CS, Venkatesh HS, Chaumeil MM, Brandes AH, VanCriekinge M, Dafni H, Sukumar S, Nelson SJ, Vigneron DB, Kurhanewicz J, James CD, Haas-Kogan DA, Ronen SM. Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized (13)C magnetic resonance spectroscopy. Cancer Res. 2010; 70(4): 1296-1305.
17. 1-pyruvate transport and metabolism in living human breast cancer cells. Proc. Natl. Acad. Sci. USA 2009; 106(43): 18 131-18 136.
18. 13C label exchange between pyruvate and lactate in tumor cells. J. Biol. Chem. 2011; 286(28): 24 572-24 580.
19. Kettunen MI, Kennedy BW, Hu DE, Brindle KM. Spin echo measurements of the extravasation and tumor cell uptake of hyperpolarized [1-(13)C]lactate and [1-(13)C]pyruvate. Magn. Reson. Med. 2012; in press.
20. Jensen PR, Karlsson M, Meier S, Duus JO, Lerche MH. Hyperpolarized amino acids for in vivo assays of transaminase activity. Chem. Eur. J. 2009; 15(39): 10 010-10 012.
21. 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Res. 2008; 68(20): 8607-8615.
22. 13C allows a direct measure of flux through a single enzyme-catalyzed step by NMR. Proc. Natl. Acad. Sci. USA 2007; 104(50): 19 773-19 777.